BetterLife Pharma Inc C.BETR

Alternate Symbol(s): BETRF

Healthcare

BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical and is a non-hallucinogenic and non- controlled lysergic acid diethylamide (LSD) derivative in development and that is unregulated and therefore can be self-administered. Its synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent, for composition and method of use, covers treatment of major depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders. BETR-002, which is in preclinical and is based on honokiol, the active anxiolytic ingredient of magnolia bark. Its pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency. It also owns a drug candidate for the treatment of viral infections.

CSE:BETR - Post by User

BetterLife Pharma Inc > Ladies get your panties on

<< Previous

Bullboard Posts

Next >>

Post by elgin1on Dec 21, 2020 5:15pm

223 Views

Post# 32155111

Ladies get your panties on

New Covid mutation , vaccine is useless . Betr's interferon Alpha puffer has no side effects, no needles , can potentially reduce any Covid mutation complications. Get that clinical trial going. Bol 148 is not too shabby either, no side effects unlike Lucy from mindmend.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market